Zdrowie i gospodarka · 07/11/2002

FDA Clears Sodium Tetradecyl Sulfate Injection for Approval

The US Food and Drug Administration (FDA) has ruled that sodium tetradecyl sulfate injection (Sotradecol) was not withdrawn from sale due to safety or efficacy concerns, paving the way for the approval of abbreviated new drug applications (ANDAs) for the product.